Levels of circulating intercellular adhesion molecule-1 in patients with Behçet's disease

Rheumatol Int. 2002 Jan;21(4):146-8. doi: 10.1007/s00296-001-0148-9.

Abstract

The purpose of this study was to investigate the possible relationship between circulating intercellular adhesion molecule-1 (cICAM-1) plasma levels and Behçet's disease. Plasma levels of cICAM-1 were measured in 44 patients with Behçet's disease and in 30 healthy controls. cICAM-1 levels were higher in patients with Behçet's disease than in the controls (P=0.001). The difference was more marked between patients with active Behçet's disease and controls (P < 0.001). cICAM-1 levels were also higher in patients with active Behçet's disease than in those with inactive disease (P<0.001). cICAM-1 seems to be related to disease activity in Behçet's disease. It may be useful in assessing disease activity in Behçet's disease, as well as in monitoring response to treatment.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Behcet Syndrome / blood*
  • Behcet Syndrome / physiopathology*
  • Biomarkers / blood
  • Case-Control Studies
  • Cohort Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Intercellular Adhesion Molecule-1 / blood*
  • Male
  • Reference Values
  • Sensitivity and Specificity
  • Severity of Illness Index

Substances

  • Biomarkers
  • Intercellular Adhesion Molecule-1